Insider · CIK 0001218180
Artal International S.C.A.
Reports to the SEC for 13 companies · LUXEMBOURG
Transactions
30
Companies
13
Filings
8
CIK
0001218180
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-11-18 | CAVACAVA GROUP, INC.S Sale | −$1.07B |
| 2024-08-26 | CAVACAVA GROUP, INC.S Sale | −$698M |
| 2024-06-05 | CAVACAVA GROUP, INC.S Sale | −$262M |
| 2024-05-10 | LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion | — |
| 2024-05-10 | LXRXLEXICON PHARMACEUTICALS, INC. · Series A Convertible Preferred StockA Award | +$125M |
| 2024-05-10 | LXRXLEXICON PHARMACEUTICALS, INC. · Series A Convertible Preferred StockM Exercise/Conversion | — |
| 2024-03-21 | CAVACAVA GROUP, INC.S Sale | −$133M |
| 2024-03-13 | LXRXLEXICON PHARMACEUTICALS, INC.A Award | +$125M |
| 2024-02-27 | CAVACAVA GROUP, INC.S Sale | −$188M |
| 2023-06-20 | CAVACAVA GROUP, INC. · Series D Preferred StockM Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC. · Series E Preferred StockM Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC. · Series F Preferred StockM Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC.M Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC.M Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC.M Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC.M Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC.M Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC.M Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC. · Series A Preferred StockM Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC. · Series B Preferred StockM Exercise/Conversion | — |
| 2023-06-20 | CAVACAVA GROUP, INC. · Series C Preferred StockM Exercise/Conversion | — |
| 2023-06-05 | LXRXLEXICON PHARMACEUTICALS, INC.P Purchase | +$72.2M |
| 2022-08-05 | LXRXLEXICON PHARMACEUTICALS, INC.P Purchase | +$6.07M |
| 2022-08-01 | LXRXLEXICON PHARMACEUTICALS, INC.P Purchase | +$40.4M |
| 2020-12-16 | LXRXLEXICON PHARMACEUTICALS, INC.P Purchase | +$35M |
| 2018-05-29 | SRRKScholar Rock Holding Corp · Series C Preferred StockC Conversion | — |
| 2018-05-29 | SRRKScholar Rock Holding CorpP Purchase | +$6.3M |
| 2018-05-29 | SRRKScholar Rock Holding CorpC Conversion | — |
| 2014-11-26 | LXRXLEXICON PHARMACEUTICALS, INC.P Purchase | +$150M |
| 2012-10-23 | LXRXLEXICON PHARMACEUTICALS, INC.P Purchase | +$6.75M |
Recent filings
- 4Artal Group S.A.0000950170-24-129313SEC(opens sec.gov)
- 4Artal Group S.A.0000950170-24-101420SEC(opens sec.gov)
- 4Artal Group S.A.0000950170-24-070715SEC(opens sec.gov)
- 4Artal Group S.A.0000950170-24-059789SEC(opens sec.gov)
- 4Artal Group S.A.0001193805-24-000441SEC(opens sec.gov)
- 4Artal Group S.A.0000950170-24-031072SEC(opens sec.gov)
- 4Artal Group S.A.0001193805-24-000286SEC(opens sec.gov)
- 4Artal Group S.A.0000899243-23-016247SEC(opens sec.gov)
Companies
- Blue Buffalo Pet Products, Inc.Director, 10% Owner
- CAVA GROUP, INC.DirectorCAVA
- Ceres, Inc.Director, 10% Owner
- CRESCENT BIOPHARMA, INC.10% OwnerCBIO
- Furiex Pharmaceuticals, Inc.Director, 10% Owner
- Generation Bio Co.10% OwnerGBIO
- LEXICON PHARMACEUTICALS, INC.Director, 10% OwnerLXRX
- MEMORY PHARMACEUTICALS CORP10% Owner
- Omega Therapeutics, Inc.10% Owner
- Scholar Rock Holding Corp10% OwnerSRRK
- Seer, Inc.10% OwnerSEER
- SQZ Biotechnologies Co10% Owner
- WW INTERNATIONAL, INC.10% OwnerWW
Address
VALLEY PARK 44, RUE DE LA VALLEE
LUXEMBOURG, L-2661